Publication:
Serum prolidase, malondialdehyde and catalase levels for the evaluation of oxidative stress in patients with peripheral vertigo.

Simple item page
dc.contributor.authorOzbay, Isa
dc.contributor.authorTopuz, Muhammet Fatih
dc.contributor.authorOghan, Fatih
dc.contributor.authorKocak, Havva
dc.contributor.authorKucur, Cuneyt
dc.date.accessioned2023-05-16T15:35:44Z
dc.date.available2023-05-16T15:35:44Z
dc.date.issued2021-09-30T21:00:00Z
dc.description.abstractWe aimed to evaluate oxidative stress in patients with peripheral vertigo by measuring serum prolidase, malondialdehyde (MDA) and catalase levels.
dc.description.abstractA total of 30 patients (age: 60 <) with peripheral vertigo and 30 healthy subjects were recruited. Blood samples were collected from both groups and serum prolidase levels were measured using enzyme-linked immunosorbent assay (ELISA). MDA and catalase levels were measured by the spectrophotometric method.
dc.description.abstractThe most common cause of vertigo was BPPV (53.3%), followed by Ménière's disease (16.6%), vestibular neuritis (13.3%), lateral semicircular canal fistula (3.3%), and idiopathic vertigo (13.3%). Mean serum prolidase activity and MDA levels were significantly higher in the vertigo patients than in the control subjects (P < 0.05); however, there was no statistically significant difference in mean serum catalase levels between the groups (P > 0.05).
dc.description.abstractWe concluded that serum prolidase and MDA levels may be used as markers of oxidative stress in patients with peripheral vertigo.
dc.identifier.pubmed33169181
dc.identifier.urihttps://hdl.handle.net/20.500.12645/37994
dc.language.isoen
dc.subjectCatalase
dc.subjectMalondialdehyde
dc.subjectOxidative stress
dc.subjectPeripheral vertigo
dc.subjectProlidase
dc.titleSerum prolidase, malondialdehyde and catalase levels for the evaluation of oxidative stress in patients with peripheral vertigo.
dspace.entity.typePublication
local.indexed.atPubMed

Files

Collections

Pubmed Ek Yayınlar